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ABSTRACT
OBJECTIVE: To describe the current process of social participation in the incorporation of 
health technologies in Brazil, within the context of the Unified Health System (SUS).  
METHODS: A descriptive study was conducted based on the analysis of official records of the 
actions of the National Committee for Health Technology Incorporation into Unified Health 
System and its website, from the beginning of its activities in January 2012 until December 2017. 
RESULTS: The findings indicate that, in Brazil, there are legal instruments related to social 
participation in health, including the health technology assessment (HTA) field. However, its 
implementation is relatively recent and has been carried out gradually. In addition to the legal 
instruments (National Health Council representative, public consultation and public hearing 
forecast), other information and transparency strategies have been shown to be allied to social 
participation in the incorporation of health technologies. However, activities such as legally 
provided public hearings have not yet been carried out. 
CONCLUSIONS: Several actions to foster social participation were developed over the analyzed 
period, but they need to be evaluated in order to maintain or improve them. In addition, there 
is a need for more qualified social participation in the various existing spaces, including those 
prescribed by law. 
DESCRIPTORS: Technology Assessment, Biomedical  Community Participation. Unified 
Health System.
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INTRODUCTION
Health technology assessment (HTA) is a multidisciplinary field of public policy analysis 
that studies the clinical, social, ethical, and economic implications of health technology 
development, diffusion, and use, considering aspects such as efficiency, effectiveness, 
safety, costs, cost-effectiveness, among others1,2. However, the ethical, legal, and social 
impacts directed to the social perspective are often disregarded due to clinical and 
economic findings3.
Members of the Health Technology Assessment International Global Policy Forum reported 
that practitioners in this area had been focusing on reporting and internal processes for a 
few years, interacting in a limited way with society; nowadays, however, this perspective 
has changed. HTA practitioners are increasingly seeking colloquial evidence, a term that 
covers different types of informal opinion4, to complement data from randomized controlled 
trials. The goal is to focus on various aspects, not just clinical ones, and thus increasingly 
adapt HTA processes to the real contexts where these technologies are or will be used5.
Literature proposes different terms to refer to the various groups of HTA end users, such 
as patients, consumers, citizens and the public. The model developed by Gauvin et al.6 
grouped these users into two categories. The first category audience provides a social or 
lay perspective on health technologies that includes citizens, groups of citizens or elected 
representatives. The second category comprises those directly affected by a particular health 
condition or technology and includes patients, service users, and entities that represent them. 
The model described above emphasizes three main aspects: domains of involvement 
(organizational policy and research), type of audience (lay and directly affected) and level 
of involvement (information, consultation and participation)7.
As patient engagement increases, individuals become more aware of their rights and begin 
participating in their own health care, which calls for effective means to involve civil society 
in decision-making on technology incorporation. Many HTA agencies in different countries 
have considered various ways to incorporate patients’ perspectives into their models and 
methods of social engagement, thus requiring a patient-centered HTA7,8.
Terminological consensus on this involvement is still lacking. International studies 
addressing the topic often use the terms “public and patient engagement”, “public 
engagement” or “patient engagement”4. In this study, the term “social participation” was 
adopted, as this is how Brazilian legislation refers to the theme, including when dealing 
with HTA9.
In Brazil, social participation is one of the guidelines of the Unified Health System (SUS) 
present in the Federal Constitution10 and is one of the principles described in Laws 
8.080/199011 and 8.142/199012. Society built social control in SUS, with health councils and 
conferences, defining spaces for social participation in the formulation and deliberation of 
public health policy13. However, this participation in contemporary democratic societies is 
a recent fact14. Although community participation is constitutionally assured, the Brazilian 
examples of democratic health experience in this area are still punctual15,16. Moreover, 
according to Delduque and Bardal (2008)15, the social participation mentioned is not 
restricted to the social control of health. That is, it does not only refer to the formation of 
councils or health conferences, but rather to a broader participation, one inherent in the 
full fulfillment of citizenship, allowing citizens to truly participate, in the Habermasian 
sense17,18, in communicative action and healthcare decision-making processes15.
Law 12.401/2011 defines that the incorporation, exclusion or alteration into SUS of new 
drugs, products and procedures, as well as the constitution or alteration of clinical protocols 
and therapeutic guidelines (PCDT), are attributions of the Ministry of Health, advised by 
the National Committee for Health Technology Incorporation into Unified Health System 
(Conitec)19. Conitec’s operating structure is composed of two forums: plenary and executive 
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secretary. One of the duties of the executive secretariat, performed by the Department 
of Management and Incorporation of Health Technologies and Inovation (DGITIS), is to 
promote actions that favor and stimulate social participation in the health technology 
incorporation into SUS9; this attribution dialogues with the National Policy of Social 
Participation and the National System of Social Participation20. 
The same law19 also formalized social participation in the technology incorporation 
process, which previously did not have this legal provision, and there were few attempts 
to involve the public and the patient before Conitec16. This participation, therefore, 
currently occurs through the Conselho Nacional de Saúde (CNS – National Health 
Council), which represents SUS users, as a member of the Conitec plenary; holding a public 
consultation (PC) for all recommendations issued; and public hearing before the final 
decision is taken, in cases in which the secretary of the Ministry of Health’s Secretariat 
of Science, Technology and Strategic Inputs determines that the relevance of the matter 
justifies its realization. 
However, recently, Decree 9.759/2019 was published, which “extinguishes and establishes 
guidelines, rules and limitations for federal public administration colleges”, an action 
that goes against social advances, causing insecurity regarding the maintenance of social 
participation in various scenarios in our country. 
This study aims to describe the current state of social participation in health technology 
incorporation processes developed by Conitec. 
METHODS 
This investigation is characterized as a case study on social participation in the technology 
incorporation process developed by Conitec in the context of SUS. To this end, documentary 
analysis21 and description of the actions that promoted social participation in the health 
technology assessment and incorporation between January 2012 and December 2017 were 
made. We described all actions developed by Conitec that aimed to reach society and 
encourage its participation, then analyzed their results. They were shown in a timeline, 
describing the moment of their publication, execution or implementation, in case of 
continuous actions.
To describe the actions taken, the number of reports to society published by Conitec, the 
number of public consultations performed, as well as the count and classification of the 
authors of the suggestions received were computed. The classification of these authors’ 
suggestions was performed according to the model by Gauvin et al. (2010)6, indicating 
those directly affected by a particular health condition or technology, and according to 
the registration of the SUS form (FormSUS).
To obtain data related to the results of Conitec’s actions, the spreadsheets and DGITIS 
management information system were consulted, as well as the committee’s electronic 
portal (www.conitec.gov.br). 
This study is part of the research project entitled O envolvimento do público e do paciente 
no processo de incorporação de tecnologias em saúde no Brasil (The patient and public 
involvement in the Brazilian health technology incorporation process), which was approved 
by the Research Ethics Committee of the Faculdade de Ceilândia, University of Brasilia, 
under the opinion no. 2.225.660.
RESULTS
Figure 1 shows a timeline with events related to social participation in the health technology 
incorporation process into SUS. The actions are described in detail according to the following 
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classification: public consultation (PC); representation of patients in plenary; surveys; and 
information and transparency. 
Public Consultation
According to the National Policy for Social Participation, public consultation is a 
“participatory mechanism, to be held within a defined period, of an advisory nature, open 
to any interested party, which aims to receive written suggestions from civil society on a 
given subject, in the form defined in its act of calling”20.
In the health technology incorporation into SUS, the objective of PC is to broaden the 
discussion on the subjects under analysis, bypassing the technical, scientific, economic 
and logistic aspects already identified. Also, the vision and experiences of patients, 
health professionals, citizens and other social actors are added to the discussion. Thus, 
after preparing a technical report, Conitec makes it available on its website to receive 
suggestions from society for 20 days. All suggestions are compiled and taken to the plenary 
for consideration prior to issuing the final recommendation on incorporation22.
In order to improve the suggestions of PC, in 2014 a new form was created to differentiate 
the reports of experiences and perspectives of patients, caregivers and health professionals 
from those technical and scientific reports.
In 2015, the DGITIS started producing reports to society, which are summarized versions 
of Conitec’s technical reports, made available to them at PC moment. They are designed in 
simplified language to improve users’ understanding of the technologies being analyzed 
and to encourage their participation in the HTA process. Until December 2017, 76 reports 
have been published to society.
In the period investigated, 257 PC were performed, with 42,630 suggestions by the various 
stakeholders, mainly family members, friends or caregivers of patients; health professionals; 
SUS patients/users; and actors interested in the theme (Figure 2). In the authors’ analysis of 
the suggestions according to the classification by Gauvin et al.6, it is observed that almost 
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PCDT: clinical protocols and therapeutic guidelines.
Figure 1. Timeline of actions involving public and patients in the evaluation and incorporation processes of technologies in SUS developed 
since the creation of Conitec until December 2017. Source: Conitec, 2018.
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half of the participants (44.6%, n = 19,006) fit into the category of those directly affected 
by a particular condition or health technology (SUS patients and users; family, friends or 
caregivers; and patient groups, organizations or associations). 
As of 2014 (Figure 1), Conitec’s executive secretary aimed to expand PC information through 
some digital social media such as institutional Twitter, partner’s channels, institutional 
LinkedIn (which was created and closed in 2017), website and email lists. Following 
the implementation of these strategies, social participation in PC increased from 2,584 
suggestions in 2014 to 13,619 suggestions in 2015 and 16,514 suggestions in 2017 (Figure 3). 
In addition to the information strategy adopted, it was observed that topics of great popular 
appeal also interfered with the increase of consultations, such as: “Exclusion of beta 
interferon for the treatment of multiple sclerosis” (4,846 suggestions) and “Guidelines for 
pregnant women: the Caesarean section operation” (3,706 suggestions) in 2015; and “PCDT 
for HIV Pre-Exposure Prophylaxis (PrEP)” (3,773 suggestions) and “Dimethyl fumarate for 
multiple sclerosis” (1,813 suggestions) in 2017.
Figure 2. Type of public participating in public consultations conducted by the National Committee 
for Health Technology Incorporation (as self-declared in the public consultation forms), from 2012 to 
2017. Source: Conitec, 2018.
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Figure 3. Number of public consultations and suggestions received per year until December 2017. 
Source: Conitec, 2018.
0
2,000
4,000
6,000
8,000
10,000
12,000
14,000
16,000
18,000
0
10
20
30
40
50
60
2012
PC Suggestions 
20172016201520142013
6Social participation in technology incorporation Silva AS et al.
https://doi.org/10.11606/S1518-8787.2019053001420
In some cases, the considerations received during the PC influenced the decision-making 
of the committee, changing the initial recommendation of non-incorporation to a final 
recommendation of incorporation, either by providing new scientific evidence and pricing 
proposals, or by bringing needs and preferences of patients who had not been included in 
the previously defined outcomes (Table 1). However, so far, no information on the quality 
or content analysis of suggestions has been published, which could guide the qualification 
of this participation tool.
Conitec Plenary Patient Representation
The Conitec plenary has as its member a representative of the CNS. However, the 
participation of other representatives of society and patients may still occur in other ways, 
which, although scarce, are important from the perspective of the quality of suggestions 
— colloquial evidence — to support decision-making in plenary.
At times, when requested by the plenary, patient representatives and experts on the 
subject were invited to attend the plenary sessions. This participation provided Conitec 
with very informative colloquial evidence on the experience of patients and experts on 
the topic4,23,24.  
It is important to point out that, at other times, in plenary meetings, the presence of 
representatives of society (professionals or patients) was accepted when requested by 
them. In these cases, those attendents could only follow the technical presentation of the 
topic, but not the subsequent discussion of the plenary. However, the law provides for a 
public hearing to be held when the relevance of the matter justifies it19. According to the 
National Policy for Social Participation, the public hearing is a “participatory, face-to-face, 
consultative mechanism open to anyone interested, with the possibility of oral expression 
by participants, whose purpose is to subsidize governmental decisions”20. However, in the 
period investigated, no record of use of this mechanism was found.    
Surveys
In 2015, aiming to investigate the needs and preferences of SUS users and to continue the 
process of improving social participation and transparency of Conitec processes, DGITIS 
announced the holding of surveys related to PCDT. They are available on the Conitec website, 
usually for 20 days, as prior consultation, still in the first stage of PCDT construction. Thus, 
the executive secretary can discuss and improve the initial proposal of the document by 
Table 1. Topics that had the recommendation “non-incorporation” changed to “incorporation” after 
analyzing the suggestions received at public consultations until December 2017.
Year Technology Indication Reason for change after PC
2013
Erlotinib and 
gefitinib
Advanced or metastatic non-small 
cell lung cancer EGFR mutation
Presentation of new evidence in PC showed 
benefit of technology (increased progression-free 
survival)
2015
Subcutaneous 
abatacept
Moderate to severe rheumatoid 
arthritis
Presentation of new price proposal received at PC 
equated the analyzed TS with the comparator, due 
to its non-inferiority
2015
Rivastigmine 
transdermal 
patch
Mild and moderately severe 
Alzheimer’s dementia
Presentation of new price proposal received at PC 
equated the analyzed TS with the comparator, due 
to its non-inferiority
2017 Fingolimod
Recurrent remitting multiple 
sclerosis after beta-interferon or 
glatiramer therapy failure
Review of currently recommended SUS lines of 
treatment and availability of a generic drug
2017
Rapid-acting 
analog insulin
Type I diabetes mellitus 
Reconsideration of the importance of other 
outcomes, incorporation recommendation made 
through price negotiation with the manufacturer
2017
Dimethyl 
Fumarate
Recurrent remitting multiple 
sclerosis after beta-interferon or 
glatiramer therapy failure
Presentation of new price proposal received at PC 
equated the analyzed TS with the comparator, due 
to its non-inferiority
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identifying aspects that may not have been previously considered. This was the way the 
commission itself found to implement other forms of social participation since the beginning 
of the PCDT elaboration process, and not only in PC.
Thus, any society actors can suggest information on certain aspects of the illnesses with 
which they have experience (personal or professional), improvements in health care and 
appeal for new technologies that should be addressed. As this participation occurs before 
the document is prepared, society contributes to the construction of the scope of the 
protocol in question. During the analyzed period, 17 surveys were conducted on the most 
diverse topics (Table 2).
Information and Transparency
The strategies adopted to promote information and transparency are shown in Figure 1.
The Conitec website, created at the end of 2014, was elected by its executive secretary as 
the basis for information and transparency initiatives24, as it allows access to all technical 
reports and suggestions received in the PC already made, as well as agendas and minutes of 
the plenary meetings. According to the institutional access analysis using Google Analytics, 
from January 2015 to December 2017, the Conitec portal had 482,524 sessions. 
In the social participation section of this website, created in June 2016, it is possible to access, 
for example, the ongoing and closed PC and surveys, the reports to society and monthly 
clippings about Conitec’s activities. According to the institutional access analysis using 
Google Analytics, this section gained 2,306 views (until December 2017). 
In 2016, Conitec launched the guide Understanding the incorporation of health technologies 
into SUS: how to get involved25 available from the Social Participation section of the website, 
Table 2. Surveys related to clinical protocols and therapeutic guidelines (PCDT) conducted by Conitec 
until December 2017.
Survey 
no.
Year Topic
No. of 
suggestions 
01 2015 Rare disease PCDT 1,140
02 2015
Proposed scope of diagnostic and therapeutic guidelines for pesticide 
poisoning
38
03 2016 Proposed update of PCDT published in 2012 and 2013 1,054
04 2016
Proposed elaboration of PCDT for the care of individuals with 
Chagas disease
37
05 2016 PCDT scope proposal for visceral and cutaneous leishmaniasis 11
06 2016
Scope proposal for Brazilian guideline for the use of coronary stent 
angioplasty 
10
07 2016 PCDT 2014 Update 304
08 2017 PCDT scope proposal for Rocky Mountain spotted fever 5
09 2017 PCDT scope proposal for malaria 1
10 2017 PCDT scope proposal for chikungunya 4
11 2017 Proposed scope of PCDT review and update for nicotine addiction 192
12 2017
Scope proposal of diagnostic guidelines for malignant pleura 
mesothelioma
12
13 2017
Preparation of Conitec technology incorporation proposal submission 
guide
62
14 2017
Proposed PCDT scope for hormone therapy in transsexualising 
process
78
15 2017 Scope proposal of the Primary Healthcare protocol – chronic pain 116
16 2017
Scope proposal of the Brazilian directive for thoracic aortic 
endoprostheses
0
17 2017 Scope proposal for pulmonary arterial hypertension guideline 627
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to inform and facilitate the engagement of society. The document was also printed and 
distributed at events, and was sent to various institutions. 
In the second half of 2017, the forum “Understanding the incorporation of health technologies” 
took place. This event was directed to patient representatives, who had the opportunity to 
discuss the Conitec’s social participation process with the executive secretary’s members. 
A total of 103 patient representatives from associations of various diseases and regions 
of the country were present, who were able to better understand the points foreseen for 
social participation and provide suggestions for improvement, which were presented to the 
Conitec plenary later. All material related to the event was made available on the social 
participation section of the Conitec website. 
In addition, between August 2016 and December 2017, DGITIS held video conferences 
every two weeks through a program called “Conitec in evidence”, which aimed to discuss 
and deepen relevant topics of technology management and evaluation with the most 
various actors in the area, as well as disseminating the content produced by Conitec and 
the Núcleos de Avaliação de Tecnologias em Saúde (NATS – Health Technology Assessment 
Centers). In addition to the participation of various institutions via videoconference, 
any citizen could follow the transmission of content in real time and ask questions via 
e-mail and institutional Twitter. Although the program ended in 2017, its content remains 
available on the Conitec website. In the analyzed period, 25 programs were carried out on 
various issues related to HTA, one of them being “Participação social para o fortalecimento 
da ATS: avanços e desafios” (Social Participation for the Strengthening of HTA: Advances 
and Challenges).
DISCUSSION 
There are numerous studies reporting experiences of participation and increased attention 
to patient involvement in HTA around the world3,5,8. 
Engagement processes differ among HTA agencies around the world, especially in terms 
of domains and types of engagement, audience types, and how much that involvement 
influences decisions about incorporating technologies into health systems26. 
Early Brazilian experience shows that it can adapt to the context and particularities of 
the national HTA. However, despite the advances already made with the formalization of 
social participation in HTA8,19,22,27, engaging society in these activities remains challenging. 
In addition to the legally foreseen participation mechanisms, especially those related to the 
PC, we have observed the experimentation of various strategies by the Conitec executive 
secretary since their implementation. 
Given that the representation of the CNS as a member of the committee is insufficient due 
to the impossibility of representing the public involved in all evaluated topics, and even 
though attempts are made to represent patients at Conitec plenary sessions when requested 
by the plenary, we suggest that this mechanism of (active) participation during plenary 
sessions, with appropriate and previously defined methodology, be strengthened. Another 
strategy to explore would be the public hearing, a planned mechanism19, but not yet used. 
Widely mentioned in Brazilian law as one of the main mechanisms for social participation in 
public management, it is consultative and allows society to express its wishes and opinions, 
providing subsidies for decision making28.
The implementation of strategies for participation, transparency, knowledge translation and 
social appropriation of knowledge developed by Conitec seems to stimulate the public to 
participate in the process of health technology incorporation. To corroborate this statement, 
there was an increase of more than 400% in the number of annual suggestions in PC from 
2014 to 2015. Some communication actions were discontinued in 2017, such as LinkedIn 
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and the “Conitec in evidence” videoconferencing program; however, no evaluation records 
were found of these strategies that justified their interruption.
It is also emphasized that the social appropriation of knowledge should be improved, taking 
into account the participation of all, including a possible reformulation process, considering 
their perspectives so that this improvement overcomes potential barriers and recognizes 
facilitators pointed out as important by the SUS users themselves. In this sense, both 
initiatives were important strategies: the launch of the guide Understanding the incorporation 
of health technologies into SUS: how to get involved and the event of the same name. 
An international survey showed that, among HTA institutions involving society, 
consultation and information mechanisms are the most common29. Since Conitec’s main 
social participation strategy is PC23 and there is an effort to improve participation and 
transparency, we conclude that the Brazilian institution has strategies aligned with those 
used by most international HTA agencies.
The obligation to submit all proposals to PC, established with the creation of Conitec, 
in theory, opens the possibility of (passive) social participation. However, according 
to Petramale et al.27 – technicians and analysts responsible for implementing social 
participation and HTA processes in the context of the Brazilian Ministry of Health –, this 
isolated initiative is unlikely to raise social participation.
In 2013, Silva et al.16 developed proposals to improve the involvement of the public and 
patients in HTA processes and incorporation of health technologies in the Brazilian context, 
from the perspective of SUS. Some of these proposals were implemented by DGITIS, such 
as: creation of reports in language appropriate to the public; increased public consultation 
disclosure; use of information and communication technology tools and training for patients. 
However, the importance of developing strategies for earlier and more active participation 
during all stages of the HTA process developed and implemented by Conitec is emphasized. 
An example of this is surveys, conducted early in the process of drafting the PCDT and 
which have included the perspective of society since the scope of these documents. 
However, they deserve to be better disclosed, as some made little or no contribution, as 
explained in Table 2.
According to our findings and experience from other agencies3,6,29 the strategies for social 
participation in Conitec processes that seem to have the greatest implementation potential 
today are: participation of patient representatives of the issues reviewed at all Conitec 
plenary sessions; formation of expert patients committees; implementation of active 
participation methodologies (e.g. citizens’ jury) on the various evaluated topics; holding 
public hearings; training and support for users of public consultations, as well as improving 
the methodology to analyze PC’s suggestions.
It is known that a closer relationship with society is possible and we must consider that the 
spaces of participation are relatively new from an institutional point of view. The results 
allow us to state that Conitec has advanced in the development and implementation of a 
variety of social participation strategies in the incorporation of health technologies into 
SUS, although they need improvement. 
For society to be increasingly involved in the health technology incorporation process* in 
Brazil, it is important that policymakers, managers and their supporters carefully plan and 
evaluate the strategies to be used. This is one of the weaknesses identified in the Conitec 
process: the lack of impact evaluation of the strategies and the quality of the suggestions 
received in PC. It is also important to defend and qualify the established spaces, the 
actors involved and think about new methodologies, so that many of the challenges are 
solved or mitigated with practice, especially in the current Brazilian moment, when a 
recently published decree can bring significant negative impacts to social participation 
in the country.
10
Social participation in technology incorporation Silva AS et al.
https://doi.org/10.11606/S1518-8787.2019053001420
REFERENCES
1. Banta HD, Luce B. Health care technology and its assessment. London: Oxford University Press; 
1993. cap. 1-6. 
2. Goodman CS; The Lewin Group. TA 101: introduction to health care technology assessment. 
Bethesda, MD: National Library of Medicine; 1998. Available from: https://www.nlm.nih.gov/
nichsr/ta101/ta101.pdf
3. Gagnon M-P, Desmartis M, Lepage-Savary D, Gagnon J, St-Pierre M, Rhainds M, et al. 
Introducing patients’ and the public’s perspectives to health technology assessment: a systematic 
review of international experiences. Int J Technol Assess Health Care. 2011;27(1):31-42. 
https://doi.org/10.1017/S0266462310001315
4. Facey K, Hansen HP, Single A, editors. Patient Involvement in health technology assessment. 
Singapura: Springer; 2017. p. 11-15, 44.
5. Sampietro-Colom L, Thomas S. Rethinking stakeholder engagement and technology access in 
health technology. assessment: reactions to policy forum discussions. Int J Technol Assess Health 
Care. 2016;32(4):200-2. https://doi.org/10.1017/S0266462316000325
6. Gauvin FP, Abelson J, Giacomini M, Eyles J, Lavis JN. “It all depends”: conceptualizing 
public involvement in the context of health technology assessment agencies. Soc Sci Med. 
2010;70(10):1518-26. https://doi.org/10.1016/j.socscimed.2010.01.036
7. Gagnon MP, Lepage-Savary D, Gagnon J, St-Pierre M, Simard C, Rhainds M, et al. Introducing 
patient perspective in health technology assessment at the local level. BMC Health Serv Res. 
2009;9:54. https://doi.org/10.1186/1472-6963-9-54
8. Silva AS, Biella CA, Petramale CA. Envolvimento do público na avaliação de tecnologias em 
saúde: experiências mundiais e do Brasil. Rev Eletron Gestao Saude. 2015 [citado 01 de junho 
de 2017];6 Supl 4:3313-37. Available from: http://periodicos.unb.br/index.php/rgs/article/
view/3340
9. Brasil. Decreto N° 9.795, de 17 de maio de 2019. Aprova a Estrutura Regimental e o Quadro 
Demonstrativo dos Cargos em Comissão e das Funções de Confiança do Ministério da Saúde, 
remaneja cargos em comissão e funções de confiança, transforma funções de confiança e 
substitui cargos em comissão do Grupo-Direção e Assessoramento Superiores - DAS por 
Funções Comissionadas do Poder Executivo - FCPE. Brasília, DF; 2019 [citado 01 de agosto 
de 2019]. Available from: http://www.planalto.gov.br/ccivil_03/_Ato2019-2022/2019/Decreto/
D9795.htm#art8
10. Brasil. Constituição da República Federativa do Brasil: promulgada em 5 de outubro de 1988. 
Contém as emendas constitucionais posteriores. Brasilia, DF: 1988. 
11. Brasil. Lei Nº 8.080, de 19 de setembro de 1990. Dispõe sobre as condições para a 
promoção, proteção e recuperação da saúde, a organização e o funcionamento dos serviços 
correspondentes e dá outras providências. Brasilia, DF; 1990 [citado 01 de junho de 2017]. 
Available from: http://www.planalto.gov.br/ccivil_03/leis/l8080.htm
12. Brasil. Lei Nº 8.142, de 28 de dezembro de 1990. Dispõe sobre a participação da comunidade 
na gestão do Sistema Único de Saúde (SUS) e sobre as transferências intergovernamentais de 
recursos financeiros na área da saúde e dá outras providências. Brasília, DF; 1990 [citado 01 de 
junho de 2017]. Available from: http://www.planalto.gov.br/ccivil_03/leis/L8142.htm
13. Ministério da Saúde (BR), Conselho Nacional de Saúde. Política nacional de educação 
permanente para o controle social no Sistema Único de Saúde – SUS. Brasília, DF; 2006 
[citado 01 de junho de 2017]. Available from: http://conselho.saude.gov.br/biblioteca/livros/
miolo_pep.pdf
14. Dallari SG, Barber-Madden R, Torres-Fernandes MC, Abdel Qader Shuqair NSMS, Watanabe 
HA. Advocacia em saúde no Brasil contemporâneo. Rev Saude Publica.1996;30(6):592-601. 
https://doi.org/10.1590/S0034-89101996000600014
15. Delduque MC, Bardal PAP. Advocacia em saúde: prática cidadã para a garantia do direito à 
saúde:o caso do Projeto de Lei Complementar nº 01/2003. Rev Direito Sanit. 2008;9(1):107-22. 
https://doi.org/10.11606/issn.2316-9044.v9i1p107-122
16. Silva AS, Marcondes WB, Elias FTS. O envolvimento do público no processo de avaliação 
de tecnologias em saúde: experiências mundiais e proposições para sua ampliação no Brasil 
[dissertação]. Rio de Janeiro: Escola Nacional de Saúde Pública Sergio Arouca; 2013.
17. Habermas J. The theory of communicative action. Vol. 1: Reason and the rationalization of 
society. Boston, MA: Beacon Press; 1984. 
11
Social participation in technology incorporation Silva AS et al.
https://doi.org/10.11606/S1518-8787.2019053001420
18. Habermas J. The philosophical discourse of modernity: twelve lectures. Cambridge, Mass: MIT 
Press; 1987. (Studies in Contemporary German Social Thought). 
19. Brasil. Lei Nº 12.401, de 28 de abril de 2011. Altera a Lei Nº 8.080, de 19 de setembro de 1990, 
para dispor sobre a assistência terapêutica e a incorporação de tecnologia em saúde no âmbito 
do Sistema Único de Saúde - SUS. Brasilia, DF; 2011 [citado 01 de junho de 2017]. Available 
from: http://www.planalto.gov.br/ccivil_03/_ato2011-2014/2011/lei/l12401.htm
20. Brasil. Decreto Nº 8.243, de 23 de maio de 2014. Institui a Política Nacional de Participação 
Social e o Sistema Nacional de Participação Social, e dá outras providências. Brasília, DF; 2014. 
21. Richardson RJ. Pesquisa social: métodos e técnicas. 3. ed. São Paulo: Atlas; 1999. 
22. Rabelo RB, Petramale CA, Silveira LC, Santos VCC, Gonçalves HC. A comissão nacional de 
incorporação de tecnologias no SUS: um balanço dos primeiros anos de atuação. Rev Eletron 
Gestão Saude. 2015; 6 Supl 4:3225-40 [citado 01 de junho de 2017]. Available from: 
https://dialnet.unirioja.es/descarga/articulo/5560377.pdf
23. Silva AS. Involving public and patients in the process of evaluation of health technologies in 
Brazil. ISPOR News Across Latin America. 2017 Sept 13 [citado 01 de junho de 2017]. Available 
from: http://press.ispor.org/LatinAmerica/2017/09/involving-public-and-patients-in-the-process-
of-evaluation-of-health-technologies-in-brazil/
24. Silva AS. Participação do público e do paciente na avaliação de tecnologias de saúde no Brasil. 
In: Toma TS, Pereira TV, Vanni T, Barreto JOM, organizadores. Avaliação de tecnologias de saúde 
e políticas informadas por evidências. São Paulo: Instituto de Saúde; 2017. (Temas em Saúde 
Coletiva, 22). p. 361-72. 
25. Ministério da Saúde (BR). Entendendo a incorporação de tecnologias em saúde no SUS: como se 
envolver. Brasília, DF; 2016 [citado 01 de junho de 2017]. Available from: http://bvsms.saude.
gov.br/bvs/publicacoes/entendendo_incorporacao_tecnologias_sus_envolver.pdf
26. Kreis J, Schmidt H. Public engagement in health technology assessment and coverage decisions: 
a study of experiences in France, Germany, and the United Kingdom. J Health Polit Policy Law. 
2013;38(1):89-122. https://doi.org/10.1215/03616878-1898812
27. Silva HP, Petramale CA, Elias FTS. Avanços e desafios da política nacional de 
gestão de tecnologias em saúde. Rev Saude Publica. 2012;46 Supl 1:83-90. 
https://doi.org/10.1590/S0034-89102012005000060
28. Maia AA. Importância da audiência pública como mecanismo de participação social em 
projetos de transportes [dissertação]. Brasília, DF: Faculdade de Tecnologia, Departamento de 
Engenharia Civil e Ambiental da Universidade de Brasília; 2015.
29. Whitty JA. An international survey of the public engagement practices of 
health technology assessment organizations. Value Health. 2013;16(1):155-63. 
https://doi.org/10.1016/j.jval.2012.09.011
Funding: This study was carried out with the support of the Coordenação de Aperfeiçoamento de Pessoal de 
Nível Superior – Brazil (CAPES), process number 88881.188553/2018-01 of 2018. 
Authors’ Contributions: Data analysis and interpretation: ASS, MSAS, EVS, DG. Preparation and writing of 
the manuscript: ASS, DG. Critical revision of the manuscript: ASS, MSAS, EVS, DG. Responsible for the content 
of the manuscript: ASS, MSAS, EVS, DG.
Conflict of Interest: The authors declare no conflict of interest. 
